ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1501	National Cancer Institute	Html	en	Childhood Hodgkin Lymphoma Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of childhood Hodgkin lymphoma.	nodular sclerosis hodgkin 0.365708 refractory pediatric Hodgkin 0.351319 refractory Hodgkin 0.416042 early Hodgkin lymphoma 0.394054 Hodgkin lymphoma cases 0.403293 Hodgkin disease-added value 0.362383 early-stage hodgkin lymphoma 0.391985 lymphocyte-predominant hodgkin 0.393688 Radiat Oncol Biol 0.45608 risk Hodgkin lymphoma 0.399452 favorable-risk Hodgkin lymphoma 0.388818 Hodgkin lymphoma histology 0.402552 pediatric hodgkin lymphoma 0.479624 German-Austrian Pediatric Hodgkin 0.419443 classic Hodgkin lymphoma 0.417403 pediatric Hodgkin disease 0.379402 high-risk Hodgkin lymphoma 0.432447 Hodgkin Study Group 0.371284 sclerosis Hodgkin lymphoma 0.410888 newly diagnosed Hodgkin 0.350548 Hodgkin lymphoma treatment 0.38529 childhood hodgkin lymphoma 0.384013 familial classical Hodgkin 0.365775 lymphocyte-predominant Hodgkin lymphoma-experience 0.349402 childhood hodgkin 0.486255	cancer survivor study 0.348591 et al. 0.539517 lymphocyte-rich classical Hodgkin 0.347809 pediatric hodgkin 0.578037 intermediate-risk hodgkin lymphoma 0.423631 advanced Hodgkin lymphoma 0.416897 refractory Hodgkin lymphoma 0.395506 PUBMED Abstract 0.412711 unfavorable pediatric Hodgkin 0.351719 Hodgkin lymphoma subtype 0.402744 Lymphocyte-predominant Hodgkin lymphoma 0.388987 advanced-stage Hodgkin 0.357413 lymphocyte predominant Hodgkin 0.374597 Abstract 0.561102 Clin Oncol 0.905331 Hodgkin Lymphoma Group 0.412086 classical Hodgkin lymphoma 0.427321 Oncol Biol Phys 0.463188 Hodgkin disease 0.410937 childhood cancer survivor 0.348315 unfavorable childhood Hodgkin 0.356068 hodgkin lymphoma 0.82441 recurrent Hodgkin lymphoma 0.392381 predominant Hodgkin lymphoma 0.394303	CLICK HERE
1513	National Cancer Institute	Html	en	Pancreatic Cancer Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of pancreatic cancer.	pancreatic carcinoma E6201 0.398831 unresectable pancreatic carcinoma 0.359985 pancreatic malignancy 0.311753 Engl J Med 0.337007 Ann Surg 0.317423 German CONKO-study group 0.318318 phase iii trial 0.413157 pancreatic tumors 0.328586 der Schelling GP 0.325496 randomized phase 0.350612 advanced pancreatic adenocarcinoma 0.470438 randomized trial 0.376847 patients 0.470655 investigational new drug 0.321651 Cooperative Oncology Group 0.454021 van der Schelling 0.325555 Moore MJ 0.343635 fixed-dose rate infusion 0.313379 pancreatic carcinoma 0.542646 Ann Oncol 0.304631 et al. 0.690156 Best supportive care 0.315629 study 0.356854 Expandable metal stents 0.329142	phase ii trial 0.320548 Hammel et al. 0.336299 Oncology Group study 0.328761 Clinical Trials Group 0.319844 gemcitabine-based induction chemotherapy 0.328647 National Cancer Institute 0.337583 den Bosch RP 0.325608 advanced unresectable pancreatic 0.366836 metastatic pancreatic cancer 0.353118 advanced pancreatic cancer 0.926655 advanced pancreatic carcinoma 0.404683 unresectable periampullary adenocarcinoma 0.332936 first-line therapy 0.306838 van den Bosch 0.324595 refractory pancreatic cancer 0.407704 advanced pancreas cancer 0.35576 Abstract 0.559395 Clin Oncol 0.91428 unresectable pancreatic cancer 0.410252 Canada Clinical Trials 0.318756 Eastern Cooperative Oncology 0.46104 drug treatment program 0.320206 gemcitabine 0.380059 active chemotherapy regimens 0.332336	CLICK HERE
1625	National Cancer Institute	Html	en	Vulvar Cancer Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of vulvar cancer.	clinical trial 0.306795 treatment 0.33468 vulvar cancer 0.816472 lymph node biopsy 0.279435 vulvar intraepithelial neoplasia 0.273676 sentinel lymph node 0.432305 cancer cells 0.248189 Recurrent vulvar cancer 0.242509	PDQ cancer information 0.200769 Radical local excision 0.22415 cancer clinical trials 0.214832 lymph nodes 0.572468 radiation therapy 0.379761 National Cancer Institute 0.219981 cancer 0.970335 clinical trials 0.629959	CLICK HERE
1637	National Cancer Institute	Html	en	Coenzyme Q10 (PDQ®)–Patient Version	Coenzyme Q10 is naturally made by the body and can be taken as a pill or injection. Studies have shown it to help protect the heart from damaging side effects of doxorubicin and to stimulate the immune system in cancer patients. Read about the results of clinical trials in cancer patients using coenzyme Q10 in this expert-reviewed summary.	cancer treatment 0.549646 body 0.488461 PDQ cancer information 0.604928 Cancer Complementary 0.504149 clinical trials 0.78289 CoQ10 supplements 0.61864 health care providers 0.511973 mg CoQ10 0.629362 cancer information summary 0.559761 alternative cancer therapies 0.503732 clinical trial 0.520374 CAM cancer research 0.490752 free radicals 0.529211 therapies 0.527068 conventional cancer therapies 0.505246 breast cancer patients 0.577878 patients 0.653188 cancer patients 0.613167 adjuvant therapy 0.48477 CoQ10 therapy 0.668716 NCI PDQ cancer 0.520611 cancer information database 0.499763 CoQ10 analogs 0.637275 Therapies Editorial Board 0.506627	cancer information 0.615008 treatment 0.639358 cancer prevention 0.483763 Complementary Therapies Editorial 0.521183 CoQ10 0.914047 Drug Administration 0.508672 Cancer Information Specialist 0.495609 cancer cells 0.510132 Cancer Information Service 0.558797 treatment clinical trials 0.486207 National Cancer Institute 0.655789 studies 0.570221 alternative medicine 0.536733 health care 0.547179 scientific journals 0.497807 Federal Trade Commission 0.485869 new treatment 0.531574 Cancer Care page 0.483491 breast cancer 0.62622 animal studies 0.506664 cancer clinical trials 0.505899 alternative therapies 0.521758 cancer information summaries 0.500194 cancer 0.924813	CLICK HERE
2027	National Cancer Institute	Html	es	Prevención del cáncer colorrectal (PDQ®)–Versión para pacientes	Sumario de información revisada por expertos sobre factores que influyen en el riesgo de presentar cáncer colorrectal y sobre las investigaciones dirigidas a prevenir esta enfermedad.	Problemas renales 0.523957 siguientes factores 0.953317 voluntarios sanos 0.523051 Physician Data Query 0.604817 siguientes afecciones 0.551171 Estados Unidos 0.609005 posibles daños 0.574254 cuerpo).ampliar anatomía 0.537676 suficiente ejercicio 0.534096 prevención revisa 0.526315	menor riesgo 0.62051 PDQ Prevención 0.545917 Antecedentes familiares 0.532247 National Cancer Institute 0.526671 tumores benignos 0.586261 siguientes riesgos 0.524072 siguientes sumarios 0.58101 alto contenido 0.561192 Instituto Nacional 0.54913	CLICK HERE
3515	National Cancer Institute	Html	en	Types of Clinical Trials	Information about the several types of cancer clinical trials, including treatment trials, prevention trials, screening trials, supportive and palliative care trials. Each type of trial is designed to answer different research questions.	agent studies 0.634708 large number 0.487416 treatment studies 0.534627 unnecessary follow-up tests 0.564207 standard treatments 0.500667 palliative care trials 0.620026 nutrition problems 0.486132 approach prevent cancer 0.592087 specific changes 0.499234 researchers 0.486118 cancer patients 0.507417 treatment trials 0.63562 Cancer prevention trials 0.614093 healthy people 0.501177 cancer screening trials 0.613302 chemoprevention studies 0.50869 health problems 0.485883 high risk 0.560244 radiation therapy 0.500589 new ways 0.649746 safe dose 0.499447 life 0.456389 answers questions 0.498733 action studies 0.564584 dietary supplements 0.491505	studies 0.663766 newer treatment trials 0.614927 certain medicines 0.490022 different research questions 0.599262 new treatment 0.895243 sleep disorders 0.486249 disease 0.456977 effective screening test 0.579302 certain type 0.487292 support groups 0.492526 people 0.64215 better quality 0.492262 genetic changes 0.499368 new treatment help 0.724782 tumors 0.439813 cancer clinical trials 0.74573 new places 0.514069 trials 0.781895 treatment help people 0.60481 cancer risk 0.517947 cancer 0.948957 prevention trials 0.744319 new cancer 0.533494 test new treatments 0.617153	CLICK HERE
3650	National Cancer Institute	Html	en	CRISPR: Genome Editing Comes of Age	A research article about a technique for gene editing known as CRISPR-Cas9. The technique has made it much easier and faster for cancer researchers to study mutations and test new therapeutic targets.	next-generation DNA sequencing 0.3795 new targets 0.314335 activator-like effector nucleases 0.397418 potentially druggable genes 0.453893 future combination therapy 0.360962 cancer therapy 0.352224 unique gene 0.31507 cancer growth 0.426678 abnormal regulatory networks 0.387625 cancer cell line 0.572636 short palindromic repeats 0.389333 genome editing 0.387426 new therapeutic targets 0.398394 genes 0.545435 cell division 0.314215 Cancer phenotypes 0.335586 human cell 0.318044 target genes 0.365123 lymphoma cells 0.394771 cancer drug targets 0.463263 drug resistant tumors 0.385077 David Baltimore 0.313639 Ji Luo 0.374003 drug resistance 0.449373	DNA sequencing 0.398873 potential combination therapies 0.357658 possible therapeutic approaches 0.357025 gene targets 0.319574 gene expression—it 0.322364 drug resistance question 0.384228 CRISPR libraries 0.319128 cancer cells 0.810099 cancer cell lines 0.446525 Dr. Luo 0.937997 Dr. Staudt 0.543567 CRISPR method 0.325677 CRISPR technology 0.334008 Hannover Medical School 0.387381 Cancer Research 0.352397 normal cells 0.431696 cancer researchers 0.367853 CRISPR 0.510355 cell death 0.314175 transformative technology 0.318261 technology 0.365907 Cancer Genome Atlas 0.450206 gene editing 0.330972 genetic changes 0.316809	CLICK HERE
4383	National Cancer Institute	Html	en	Anyone Can Get Skin Cancer	No matter if your skin is light, dark, or somewhere in between, everyone is at risk for skin cancer. Learn what skin cancer looks like, how to find it early, and how to lower the chance of skin cancer.	skin cancer 0.964567 UV rays 0.456636 dark band 0.53853 new mole 0.452556 dark patch 0.449539 body 0.421991 waxy bump 0.459872 Wear sunglasses 0.448376 ) bump. 0.459875 talk 0.420942 common sign 0.451092 skin light 0.47582 different types 0.451536 jagged scar 0.458002 exposure 0.417645 medical conditions 0.448166 sore 0.426359 UVB rays 0.455332 broad spectrum 0.449203 women 0.411421 UVA 0.425118 sunscreen 0.411184 high level 0.447722 dark skin 0.502452 changes 0.445228	skin conditions 0.464403 cancer cells 0.45646 cell skin cancer 0.522134 firm red lump 0.495754 sun 0.50802 skin tone 0.480812 eyes 0.41674 old growth 0.501248 different color 0.450303 men 0.411424 certain medicines 0.448412 advanced skin cancers 0.508812 younger children 0.460432 change 0.452939 long sleeves 0.44884 No. 0.411646 skin ulcers 0.466159 people 0.446457 doctor 0.48532 sunlight 0.422273 cause damage 0.452334 new growth 0.497988 risk 0.471314 low level 0.448421	CLICK HERE
16838	National Cancer Institute	Html	en	University of Texas — Interdisciplinary Translational Pre/Postdoctoral Program in Cancer Nanotechnology	The focus of the University of Texas MD Anderson Cancer Nanotechnology Training Center is presented here.	unique boot camp 0.665183 lab management skills 0.648892 Rice University 0.515834 M.D. 0.338543 Objectives 0.334693 MD Anderson 0.892403 preparation 0.332958 independent careers 0.500052 problem 0.335383 MD Anderson CNTC 0.66004 Ph.D. 0.338612 seminar experiences 0.507875 translational research 0.966631 academic labs 0.516268 hands-on coursework 0.547621 project management 0.489839 Konstantin Sokolov 0.587384 future leaders 0.517794 independent research project 0.702082 Texas 0.33468 cancer nanotechnology 0.891595 translational research projects 0.795763 training program 0.532137 multidisciplinary mentorship 0.538033 post-doctoral training 0.533942	trainees 0.545607 specific interests 0.517161 Rebecca 0.339233 research fellowship grant 0.692269 multidisciplinary field 0.50801 Ph.D 0.333304 cancer translational research 0.824834 Cancer Management 0.515303 gap 0.336671 Principal Investigator 0.540969 Didactic coursework 0.550767 completion 0.335106 Center 0.334629 MD Anderson Cancer 0.714625 NCI Nanotechnology Characterization 0.789772 program faculty mentors 0.704052 current opportunities 0.49661 federal resources 0.494134 new discoveries 0.52212 Sunil Krishnan 0.581597 deep understanding 0.497785 barriers 0.38628 introductory course 0.486248 Training Focus 0.539936	CLICK HERE
17278	National Cancer Institute	Html	es	Preparación para cuidar a un enfermo con cancer	Cuidar a alguien con cáncer avanzado trae desafíos y preocupaciones nuevas. Las personas que cuidan a pacientes deben estar al tanto de muchas cosas y planificar el cuidado de su ser querido.	dándoles oportunidad 0.826428 !No hables así¡ 0.973126 Nueva York 0.867641 principales formas 0.895606 Oxford University 0.86575	Lynna J 0.87542 busque consejo 0.895137 mejores tratamientos 0.878203 surgen preguntas 0.922072	CLICK HERE